β Crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
US7923569B2 · kind B2 · utility
3Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 2007 |
| Grant date | Apr 12, 2011 |
| Priority date | — |
| Expiry date | May 8, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
β-crystalline form of the compound of formula (I):characterised by its powder X-ray diffraction diagram.Medicinal products containing the same which are useful as inhibitors of angiotensin I converting enzyme.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.